New Fat-Dissolving Shot Cuts Hidden Visceral Fat in Early Human Trials

An experimental injection, CBL-514, has shown promising results in early human trials, reducing both subcutaneous and visceral fat. Visceral fat, which surrounds internal organs, is linked to various health issues. The study suggests that this new treatment could potentially help manage obesity and related health risks.